Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia

Walter Knapp; Otto Majdic; Hannes Stockinger; Peter Bettelheim; Kristof Liszka; Ursula Köller; Christian Peschel

doi:10.1007/BF02934532

Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia

Walter Knapp, Otto Majdic, Hannes Stockinger, Peter Bettelheim, Kristof Liszka, Ursula Köller, Christian Peschel

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Abstract

The immunological definition of malignant lymphatic cells has already been routinely applied by many laboratories over a number of years. Today it is clear and undisputed that the phenotypic data obtained in that way are often very useful and supporting. The immunological definition of non-lymphoid leukemias is not yet as far advanced. Additional surface markers for the recognition of poorly differentiated non-lymphoid cells are clearly needed. In this paper ten monoclonal antibodies to myeloid surface antigens are described. It is hoped that they are a useful addition to the presently available relatively small panel of well studied myeloid surface markers which are displayed by immature malignant blast cells.

Original language	English
Pages (from-to)	257-262
Number of pages	6
Journal	Medical Oncology and Tumor Pharmacotherapy
Volume	1
Issue number	4
DOIs	https://doi.org/10.1007/BF02934532
State	Published - Dec 1984
Externally published	Yes

Keywords

Differentiation antigens
Leukemia
Monoclonal antibodies
Myeloid

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/BF02934532

Cite this

@article{49c9294b866e44eb95c76e655ed04a59,

title = "Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia",

abstract = "The immunological definition of malignant lymphatic cells has already been routinely applied by many laboratories over a number of years. Today it is clear and undisputed that the phenotypic data obtained in that way are often very useful and supporting. The immunological definition of non-lymphoid leukemias is not yet as far advanced. Additional surface markers for the recognition of poorly differentiated non-lymphoid cells are clearly needed. In this paper ten monoclonal antibodies to myeloid surface antigens are described. It is hoped that they are a useful addition to the presently available relatively small panel of well studied myeloid surface markers which are displayed by immature malignant blast cells.",

keywords = "Differentiation antigens, Leukemia, Monoclonal antibodies, Myeloid",

author = "Walter Knapp and Otto Majdic and Hannes Stockinger and Peter Bettelheim and Kristof Liszka and Ursula K{\"o}ller and Christian Peschel",

year = "1984",

month = dec,

doi = "10.1007/BF02934532",

language = "English",

volume = "1",

pages = "257--262",

journal = "Medical Oncology and Tumor Pharmacotherapy",

issn = "0736-0118",

publisher = "Humana Press",

number = "4",

}

TY - JOUR

T1 - Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia

AU - Knapp, Walter

AU - Majdic, Otto

AU - Stockinger, Hannes

AU - Bettelheim, Peter

AU - Liszka, Kristof

AU - Köller, Ursula

AU - Peschel, Christian

PY - 1984/12

Y1 - 1984/12

N2 - The immunological definition of malignant lymphatic cells has already been routinely applied by many laboratories over a number of years. Today it is clear and undisputed that the phenotypic data obtained in that way are often very useful and supporting. The immunological definition of non-lymphoid leukemias is not yet as far advanced. Additional surface markers for the recognition of poorly differentiated non-lymphoid cells are clearly needed. In this paper ten monoclonal antibodies to myeloid surface antigens are described. It is hoped that they are a useful addition to the presently available relatively small panel of well studied myeloid surface markers which are displayed by immature malignant blast cells.

AB - The immunological definition of malignant lymphatic cells has already been routinely applied by many laboratories over a number of years. Today it is clear and undisputed that the phenotypic data obtained in that way are often very useful and supporting. The immunological definition of non-lymphoid leukemias is not yet as far advanced. Additional surface markers for the recognition of poorly differentiated non-lymphoid cells are clearly needed. In this paper ten monoclonal antibodies to myeloid surface antigens are described. It is hoped that they are a useful addition to the presently available relatively small panel of well studied myeloid surface markers which are displayed by immature malignant blast cells.

KW - Differentiation antigens

KW - Leukemia

KW - Monoclonal antibodies

KW - Myeloid

UR - http://www.scopus.com/inward/record.url?scp=0021689322&partnerID=8YFLogxK

U2 - 10.1007/BF02934532

DO - 10.1007/BF02934532

M3 - Article

C2 - 6599463

AN - SCOPUS:0021689322

SN - 0736-0118

VL - 1

SP - 257

EP - 262

JO - Medical Oncology and Tumor Pharmacotherapy

JF - Medical Oncology and Tumor Pharmacotherapy

IS - 4

ER -

Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this